CANF is Can-Fite BioPharma Ltd. (Healthcare) — a non-dividend-paying stock. Trading at $2.23. Market cap: $5M.
Stock snapshot
| Price | $2.23 |
| Market cap | $5M |
| Sector | Healthcare |
| Exchange | ASE |
| Pays dividend | No |
About CANF
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
Related non-dividend companies
Other non-dividend stocks investors research alongside CANF. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is CANF's current stock price?
CANF (Can-Fite BioPharma Ltd.) is currently trading at $2.23.
Does CANF pay a dividend?
CANF (Can-Fite BioPharma Ltd.) does not currently pay a regular dividend.
Track CANF in DiviDrip
Add CANF to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search CANF and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.